Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;94(7):3155-3159.
doi: 10.1002/jmv.27709. Epub 2022 Mar 22.

Comparison of extraction-based and elution-based polymerase chain reaction testing, and automated and rapid antigen testing for the diagnosis of severe acute respiratory syndrome coronavirus 2

Affiliations

Comparison of extraction-based and elution-based polymerase chain reaction testing, and automated and rapid antigen testing for the diagnosis of severe acute respiratory syndrome coronavirus 2

Nori Yoshioka et al. J Med Virol. 2022 Jul.

Abstract

We aimed to compare the differences in testing performance of extraction-based polymerase chain reaction (PCR) assays, elution-based direct PCR assay, and rapid antigen detection tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We used nasopharyngeal swab samples of patients with coronavirus disease 2019 (COVID-19). We used the MagNA Pure 24 System (Roche Diagnostics K.K.) or magLEAD 12gC (Precision System Science Co., Ltd.) for RNA extraction, mixed the concentrates with either the LightMix Modular SARS-CoV PCR mixture (Roche Diagnostics K.K.) or Takara SARS-CoV-2 direct PCR detection kit (Takara Bio Inc.), and amplified it using COBAS® z480 (Roche Diagnostics K.K.). For elution-based PCR, we directly applied clinical samples to the Takara SARS-CoV-2 direct PCR detection kit before the same amplification step. Additionally, we performed Espline SARS-CoV-2 (Fuji Rebio Co., Ltd.) for rapid diagnostic test (RDT), and used Lumipulse SARS-CoV-2 antigen (Fuji Rebio Co., Ltd.) and Elecsys SARS-CoV-2 antigen (Roche Diagnostics K.K.) for automated antigen tests (ATs). Extraction-based and elution-based PCR tests detected the virus up to 214-216 and 210 times dilution, respectively. ATs remained positive up to 24-26 times dilution, while RDT became negative after 22 dilutions. For 153 positive samples, positivity rates of the extraction-based PCR assay were 85.6% to 98.0%, while that of the elution-based PCR assay was 73.2%. Based on the RNA concentration process, extraction-based PCR assays were superior to elution-based direct PCR assays for detecting SARS-CoV-2.

Keywords: novel coronavirus disease 2019 (COVID-19); polymerase chain reaction; rapid diagnostic test; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Testing protocol. (A) Comparison of sample extraction methods (PCR condition 1 vs. 2); (B) Comparison of PCR reagents (PCR condition 2 vs. 3); (C) Comparison of extraction‐based PCR and elution‐based PCR (PCR condition 3 vs. 4), and (D) Comparison of automated antigen test and rapid diagnostic test. PBS, phosphate‐buffered saline; PCR, polymerase chain reaction
Figure 2
Figure 2
Comparison of positivity rates of each PCR and antigen detection test for 153 positive samples. We used 153 nasopharyngeal samples that were positive in either PCR testing method. PCR, polymerase chain reaction

Similar articles

Cited by

  • Performance characteristics of INDICAID antigen rapid diagnostic test on SARS-CoV-2 samples during the omicron wave in Cameroon.
    Fokam J, Takou D, Semengue ENJ, Molimbou E, Chenwi Ambe C, Durand Nka A, Ndjeyep SD, Beloumou GA, Ka'e CA, Gouissi Anguechia DH, Mundo Nayang AR, Moko Fotso LG, Kengni Ngueko AM, Etame NK, Tueguem PP, Tommo Tchouaket CM, Fainguem N, Abega Abega C, Abba A, Tambe Ayuk Ngwese D, Djubgang Djoukwe R, Akenji B, Okomo Assoumou MC, Mandeng N, Esso L, Cappelli G, Shang J, Ndongmo C, Etoundi Mballa GA, Ndembi N, Colizzi V, Perno CF, Ndjolo A. Fokam J, et al. Heliyon. 2024 Apr 19;10(9):e29937. doi: 10.1016/j.heliyon.2024.e29937. eCollection 2024 May 15. Heliyon. 2024. PMID: 38694118 Free PMC article.

References

    1. Karim SSA, Karim QA. Omicron SARS‐CoV‐2 variant: a new chapter in the COVID‐19 pandemic. Lancet. 2021;398:2126‐2128. - PMC - PubMed
    1. World Health Organization . WHO Coronavirus Disease (COVID‐19) Dashboard [Internet]. 2022. Accessed January 26, 2022. https://covid19.who.int/
    1. Thomas E, Delabat S, Carattini YL, Andrews DM. SARS‐CoV‐2 and variant diagnostic testing approaches in the United States. Viruses. 2021;13:2492. - PMC - PubMed
    1. Watson J, Whiting PF, Brush JE. Interpreting a covid‐19 test result. BMJ. 2020;369:m1808. - PubMed
    1. Peeling RW, Heymann DL, Teo YY, Garcia PJ. Diagnostics for COVID‐19: moving from pandemic response to control. Lancet. 2022;399(10326):757‐768. - PMC - PubMed